Hypercapnia in Respiratory Diseases

Definition and Pathophysiology

Hypercapnia is defined as elevated arterial carbon dioxide tension (PaCO₂) above the normal range, resulting primarily from alveolar hypoventilation where minute ventilation is insufficient relative to CO₂ production, as stated by the European Respiratory Society 1
The four fundamental causes of hypercapnia are alveolar hypoventilation, increased CO₂ production, increased inspired CO₂ concentration, and increased external dead space, according to the European Respiratory Society 1

In stable COPD, chronic hypercapnia develops through a constellation of mechanical derangements rather than simple hypoventilation, as noted by the European Respiratory Society 2
Key pathophysiological features of chronic hypercapnia in COPD include dynamic hyperinflation with intrinsic PEEP, inspiratory muscle dysfunction, increased mechanical workload, and ventilation-perfusion mismatch, as reported by the European Respiratory Society 2, 4
Acute respiratory failure is characterized by significant deterioration of arterial blood gases with both hypoxemia and worsening hypercapnia, driven by increased V/Q abnormalities and alveolar hypoventilation, according to the European Respiratory Society 2, 6, 5

Non-invasive ventilation (NIV) should be initiated when pH <7.35 and PaCO₂ >6.0 kPa (45 mmHg) after optimal medical therapy in COPD exacerbations, as recommended by the British Thoracic Society 7
Controlled oxygen therapy with target saturation of 88-92% is essential to avoid worsening hypercapnia, as stated by the European Respiratory Society 3
In neuromuscular disease and chest wall disorders, any elevation of PaCO₂ may herald an impending crisis, and NIV should be initiated early, according to the British Thoracic Society 7

Arterial blood gases should be monitored after 1-2 hours of NIV and again after 4-6 hours if earlier sample showed little improvement, as recommended by the European Respiratory Society 3
Failure to improve PaCO₂ and pH after 4-6 hours indicates NIV failure and need for intubation, as stated by the European Respiratory Society 3